T. Rowe Price Capital Appreciation Fund (PRWCX)
Ticker Symbol:
PRWCX
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 30, 2014 at 4pm EST
Fund Composition
Asset Allocation
as of 07/31/2017
Domestic Stock 57.2%
Domestic Bond 18.8%
Cash 14.6%
Foreign Stock 4.4%
Convertibles 2.7%
Foreign Bonds 2.2%
Preferreds 0.7%
Options -0.6%
Volatility and Other Measures
as of 07/31/2017
Beta 0.62
0.90
Standard Deviation 6.66
Price/Earnings Ratio (Domestic) 20.3
Earnings Growth Rate (Domestic) 11.2
Turnover Rate 28.7
Median Market
Capitalization
$51,184.63 Million
Sector Diversification
as of 07/31/2017
% of Total Net Assets
Health Care 17.6%
Information Technology 12.3%
Consumer Discretionary 8.4%
Financials 7.5%
Consumer Staples 6.4%
Industrials & Business Services 4.9%
Real Estate 3.1%
Utilities 2.4%
Energy 1.5%
Materials 0.3%
10 Largest Holdings
Represents 25.69 % of Total Net Assets
View Holdings as of:
Abbott Laboratories
Alphabet
Bank of New York Mellon
Becton, Dickinson & Company
Danaher
Fiserv
Marsh & McLennan
Microsoft
Philip Morris International
Visa
As of 07/31/2017 the Capital Appreciation Fund had a total of 278 holdings.
See Glossary for additional details on all data elements.